SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-009922
Filing Date
2022-05-16
Accepted
2022-05-16 06:24:12
Documents
14
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elym-20220516.htm   iXBRL 8-K 74671
2 EX-99.1 elym-ex99_1.htm EX-99.1 225248
3 GRAPHIC img171973770_0.jpg GRAPHIC 60643
  Complete submission text file 0000950170-22-009922.txt   526406

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20220516_lab.xml EX-101.LAB 19058
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20220516_pre.xml EX-101.PRE 11999
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20220516.xsd EX-101.SCH 2485
8 EXTRACTED XBRL INSTANCE DOCUMENT elym-20220516_htm.xml XML 4902
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 22925297
SIC: 2834 Pharmaceutical Preparations